Susquehanna International Group
SGMO

Susquehanna International Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Susquehanna International Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$417K Sell
1,687,463
-449,657
-21% -$179K ﹤0.01% 10115
2025
Q4 		$898K Sell
2,137,120
-283,246
-12% -$150K ﹤0.01% 7424
2025
Q3 		$1.63M Buy
2,420,366
+1,647,100
+213% +$888K ﹤0.01% 6218
2025
Q2 		$419K Sell
773,266
-1,036,284
-57% -$615K ﹤0.01% 9580
2025
Q1 		$1.19M Buy
1,809,550
+1,524,637
+535% +$1.61M ﹤0.01% 6824
2024
Q4 		$291K Sell
284,913
-107,920
-27% -$197K ﹤0.01% 9903
2024
Q3 		$340K Sell
392,833
-277,285
-41% -$203K ﹤0.01% 9325
2024
Q2 		$240K Buy
670,118
+637,670
+1,965% +$345K ﹤0.01% 9957
2024
Q1 		$21.7K Sell
32,448
-73,811
-69% -$53.5K ﹤0.01% 11800
2023
Q4 		$57.7K Buy
106,259
+36,796
+53% +$17K ﹤0.01% 11656
2023
Q3 		$41.7K Sell
69,463
-231,502
-77% -$248K ﹤0.01% 11371
2023
Q2 		$391K Buy
300,965
+17,843
+6% +$24.4K ﹤0.01% 8885
2023
Q1 		$498K Buy
283,122
+133,352
+89% +$381K ﹤0.01% 8577
2022
Q4 		$470K Sell
149,770
-198,127
-57% -$769K ﹤0.01% 8029
2022
Q3 		$1.71M Buy
347,897
+165,234
+90% +$849K ﹤0.01% 5276
2022
Q2 		$757K Sell
182,663
-28,875
-14% -$125K ﹤0.01% 7217
2022
Q1 		$1.23M Sell
211,538
-52,020
-20% -$309K ﹤0.01% 6614
2021
Q4 		$1.98M Buy
263,558
+67,980
+35% +$591K ﹤0.01% 5537
2021
Q3 		$1.76M Buy
195,578
+30,339
+18% +$300K ﹤0.01% 6117
2021
Q2 		$1.98M Sell
165,239
-22,671
-12% -$257K ﹤0.01% 5938
2021
Q1 		$2.35M Sell
187,910
-91,739
-33% -$1.24M ﹤0.01% 5525
2020
Q4 		$4.36M Sell
279,649
-51,699
-16% -$606K ﹤0.01% 3643
2020
Q3 		$3.13M Sell
331,348
-129,621
-28% -$1.4M ﹤0.01% 3785
2020
Q2 		$4.13M Buy
460,969
+28,063
+6% +$260K ﹤0.01% 3278
2020
Q1 		$2.76M Sell
432,906
-176,294
-29% -$1.31M ﹤0.01% 3429
2019
Q4 		$5.1M Sell
609,200
-21,470
-3% -$197K ﹤0.01% 2943
2019
Q3 		$5.71M Sell
630,670
-11,477
-2% -$129K ﹤0.01% 2544
2019
Q2 		$6.92M Buy
642,147
+505,111
+369% +$5.37M ﹤0.01% 2312
2019
Q1 		$1.31M Sell
137,036
-459,195
-77% -$4.69M ﹤0.01% 4483
2018
Q4 		$6.84M Buy
596,231
+64,433
+12% +$800K ﹤0.01% 1944
2018
Q3 		$9.01M Buy
531,798
+120,025
+29% +$1.82M ﹤0.01% 2045
2018
Q2 		$5.85M Buy
411,773
+308,921
+300% +$5.13M ﹤0.01% 2522
2018
Q1 		$1.95M Sell
102,852
-208,478
-67% -$4.46M ﹤0.01% 3961
2017
Q4 		$5.11M Sell
311,330
-35,203
-10% -$524K ﹤0.01% 2514
2017
Q3 		$5.2M Buy
346,533
+142,799
+70% +$1.58M ﹤0.01% 2451
2017
Q2 		$1.79M Buy
203,734
+117,445
+136% +$753K ﹤0.01% 4104
2017
Q1 		$449K Sell
86,289
-153,705
-64% -$617K ﹤0.01% 6686
2016
Q4 		$732K Buy
239,994
+228,006
+1,902% +$830K ﹤0.01% 6175
2016
Q3 		$56K Sell
11,988
-87,530
-88% -$445K ﹤0.01% 8092
2016
Q2 		$576K Sell
99,518
-41,912
-30% -$267K ﹤0.01% 5885
2016
Q1 		$856K Buy
141,430
+16,030
+13% +$96.2K ﹤0.01% 5401
2015
Q4 		$1.15M Sell
125,400
-177,552
-59% -$1.37M ﹤0.01% 5140
2015
Q3 		$1.71M Buy
302,952
+126,654
+72% +$1.04M ﹤0.01% 4591
2015
Q2 		$1.96M Sell
176,298
-5,763
-3% -$74.3K ﹤0.01% 4764
2015
Q1 		$2.85M Sell
182,061
-298,067
-62% -$4.61M ﹤0.01% 3656
2014
Q4 		$7.3M Buy
480,128
+103,653
+28% +$1.26M ﹤0.01% 2374
2014
Q3 		$4.06M Buy
376,475
+177,112
+89% +$2.31M ﹤0.01% 3341
2014
Q2 		$3.04M Buy
199,363
+81,193
+69% +$1.17M ﹤0.01% 3898
2014
Q1 		$2.14M Buy
118,170
+46,936
+66% +$905K ﹤0.01% 4235
2013
Q4 		$989K Sell
71,234
-78,331
-52% -$902K ﹤0.01% 5533
2013
Q3 		$1.57M Sell
149,565
-107,389
-42% -$1.07M ﹤0.01% 4518
2013
Q2 		$2.01M Buy
+256,954
New +$2.24M ﹤0.01% 3892

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's SGMO Position: Q1 2026 in Review

Susquehanna International Group reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 21% in Q1 2026, selling an estimated $179K and leaving 1,687,463 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #10115.

Susquehanna International Group first reported a position in SGMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.01M in Q3 2018. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Susquehanna International Group held 1,687,463 shares of SANGAMO THERAPEUTICS INC worth $417K as of Q1 2026.
  • Susquehanna International Group sold 449,657 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $179K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10115 holding.
  • Susquehanna International Group first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 52 quarters since.
  • Susquehanna International Group's SANGAMO THERAPEUTICS INC position peaked at $9.01M in Q3 2018.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.